Healthcare training
- Doctor Cum Laude. Characterisation of genetic polymorphisms involved in cytarabine metabolism and association with response and toxicity to chemotherapy in patients with intermediate-risk acute myeloid leukaemia Univesitat de Girona. Doctoral School in the Molecular Biology Programme, Biomedicine and Health. December 2022.
- Master's degree with a university-awarded title in Advanced Integrative Medicine and Health. 2024.
- Specialist qualification in thromboembolic disease. Universidad de Alcalá. 2018-2019.
- Master's degree in Haematopoietic Transplantation, 5th edition. Universidad de Valencia. 2018-2019.
- Specialist in Haematology and Haemotherapy. Hospital Universitari Doctor Josep Trueta and Institut Català d'Oncologia. Girona, 2012.
- Physician and surgeon. Universidad de Caldas (Colombia). 1999-2006. Qualification recognised as the official Spanish university degree of Bachelor of Medicine.
Trajectory
Specialist doctor in Haematology.
• Haematology Service at Institut Català d'Oncologia. Girona. 2016-2020.
• Outpatient consultancy at the Haematology Department at Institut Català d'Oncologia in Girona: Referee for the following pathologies: myelodysplastic syndrome, acute myeloid leukaemia in UNFIT patients, thrombotic thrombocytopenic purpura, primary immune thrombocytopenia, paroxysmal nocturnal haemoglobinuria. 2016-2024.
• Outpatient consultation at the Haematology Service of Hospital d'Olot i comarcal de la Garrotxa, from Institut Català d'Onclogia: benign and malignant haematological pathology. 2016 and currently on temporary leave of absence. 2016-2024.
• Enquiries regarding myeloid pathology clinical trials at Institut Català d'Oncologia in Girona. 2022-2024.
• Anticoagulation, Thrombosis and Thrombophilia Unit Consultation. Institut Català d'Oncologia. Girona. 2016-2018
• Outpatient Clinic for Clinical Haematology at Clínica Girona. Benign and malignant haematological pathology. 2021-present.
• Rotation to the Transplant and Bone Marrow Aplasia Unit at Saint Louis Hospital, Paris, France. 2016.
Teaching activity
Clinical practice tutor for medical students at the Faculty of Medicine, ICS Hospital Universitari Dr. Josep Trueta. 2018-2024.
Membership
- Sociedad Española de Hematología y Hemoterapia (SEHH).
- Sociedad Española de Trombosis y Hemostasia (SETH).
- Grupo Español de Trombopenia Inmune Primaria (Gepti).
- Societat Catalana d'Hematologia i Hemoteràpia.
- Grupo Español de Síndrome Mielodisplásico (Gesmd).
- Grup Català d'Hemoglobinúria Paroxística Nocturna.
- Programa Español de Tratamientos en Hematología (Pethema).
Scientific activity
- ICO-ICS Practice for the medical treatment of immune thrombocytopenia. 2023.
- Diagnosis and Clinical Management of Thrombotic Thrombocytopenic Purpura. Second consensus protocol. Grup Català de TTP. 2022.
- Prophylaxis and treatment of venous thromboembolic disease in cancer patients. Hospital Dr. Josep Trueta. Institut Català d'Oncologia. 2017.
- Management of haemorrhage and/or urgent surgical intervention/invasive procedure in a patient being treated with oral anticoagulants. Hospital Dr. Josep Trueta. Institut Català d'Oncologia. 2017.
- Recommendations for perioperative management and invasive procedures in patients on antiplatelet therapy. Hospital Dr. Josep Trueta. Institut Català d'Oncologia. 2017.
Publications
- Hypomethylating agents for patients with VEXAS without myelodysplastic syndrome: Clinical outcome and longitudinal follow-up of vacuolisation and UBA1 clonal dynamics. Jose R. Álamo, Lucía Mont-de Torres, Sandra Castaño-Díez, Anna Mensa-Vilaró, M. Mónica López-Guerra, Ines Zugasti, Johana Díaz, __OPENROUTER_FAILED__
https://doi.org/10.1111/bjh.19953
- Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice. Tomás José González-López, Nuria Bermejo-Vega, Rocío Cardesa-Cabrera, Violeta Martínez-Robles, Gerardo Aguilar-Monserrate, Gloria Pérez-Segura, Abel Domingo, Josefa Luis-Navarro, Sunil Lakhwani, Natalia Acedo, María Luisa Lozano, Silvia Bernat, Ana Torres-Tienza, Ana Ruano, Isidro Jarque, Pilar Galán, Carmen Benet, Shally Marcellini, Reyes Jimenez-Bárcenas, Daniel Martínez-Carballeira, Dunia De Miguel-Llorente, Alvaro Perona-Blázquez, Isabel Gonzalez-Gascón, Elsa Lopez-Ansoar, José María Alonso-Alonso, María Luisa Bengochea-Casado, Francisco Javier Díaz-Gálvez, Ana Moretó, Gemma Moreno-Jiménez, Roberto Hernández-Martin, Erik de Cabo, Julio Dávila-Valls, Amalia Cuesta, Carmen Pastoriza, Gerardo Julio Hermida-Fernández, Covadonga García, Miguel Angel Pozas-Mañas, Carlos Aguilar, Dolores Fernandez-Jimenez, Begoña Navas-Elorza, Carolina López-Santamaría Castro, Alvaro Lorenzo, Xavier Ortín, Marta García, Sonia Piernas, Johana Díaz-Santa, Inmaculada Soto, Drew Provan, Gloria García-Donas Gabaldón, Blood, Volume 144, Issue 6, 2024, Pages 646-656, doi.org/10.1182/blood.2024024250.
- 5'-nucleotidase, cytosolic II genotype and clinical outcome in patients with acute myeloid leukaemia with intermediate-risk cytogenetics. Díaz-Santa J; Rodríguez-Romano R; Coll R; Osca G; Pratcorona M; González-Bartulos. M; Garrido A; Angona A; Talarn C; Tormo M; Arnan M; Vives S; Salamero O; Tuset E; Lloveras N; Díez I; Zamora L; Bargay J; Sampol A; Cruz D; Vila J; Sitges M; Garcia A; Vall-Llovera F; J; Sierra J; Gallardo D. Eur J Haematol. 2022 Dec;109(6):755-764. doi: 10.1111/ejh.13862. Epub 2022 Sep16. PMID: 36063368.
- Relevance of infections on the outcomes of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia treated with hypomethylating agents: a cohort study from the GESMD. Vilorio-Marqués L, Castañón Fernández C, Mora E, Gutiérrez L, Rey Bua B, Jiménez Lorenzo MJ, Díaz Beya M, Vara Pampliega M, Molero A, Sánchez-García J, Calabuig M, Cedena MT, Chen-Liang T, Díaz Santa JA, __OPENROUTER_FAILED__.
- UGT1A1 genotype influences clinical outcome in patients with intermediate-risk acute myeloid leukaemia treated with cytarabine-based chemotherapy Díaz-Santa, J., Rodríguez-Romanos, R., Osca, G. et al. Leukemia. 2020 Nov;34(11):2925-2933.
- Diagnosis and clinical management of thrombotic thrombocytopenic purpura (TTP): a consensus statement from the TTP Catalan group. Nadia García, Sandra Ortega, Xavier Solanich ,Joan Cid , Maribel Díaz , Ana Belen Moreno , Águeda Ancochea ,Mireia Santos, Inés Hernández , Juan Manuel Sanchez , Armando Luaña, Jose Garcí, Lourdes Escoda, Laura Medina, Gonzalo José Ferrer, Jordi López , Roberto Céspedes , Johana Alejandra Díaz , Verónica Pons, David Valcárcel and Joan Ramon Grifol. Blood Transfus. 2024 Mar;22(2):176-184. doi: 10.2450/BloodTransfus.522. Epub 2023 Sep 4. PMID: 37677097; PMCID: PMC10920070.
